Hypoglycaemia
Who is at risk for and how do you manage hypoglycaemia in patients with HF taking empagliflozin?
-
Insulin and insulin secretagogues, e.g. sulphonylureas, may increase the hypoglycemia risk
-
Consequently, a lower insulin dose or an insulin secretagogue may be needed to lower hypoglycaemia risk when patients use insulin plus empagliflozin
Note:
- HF, heart failure; UTI, urinary tract infection.
- Empagliflozin (Jardiance®) PH LPI November 2022.
- The advice in this deck should not be interpreted as official management guidelines and is not designed to replace professional judgement when assessing patients with HF.